Oxford Immunotec

About:

Oxford Immunotec, a medical diagnostics company, develops tests for various diseases based on its innovative T cell measurement technology.

Website: http://www.oxfordimmunotec.com

Twitter/X: TBDiagnosis

Top Investors: Molten Ventures, Invesco, Dow, MidCap Financial, Wellington Partners

Description:

Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Total Funding Amount:

$216M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Abingdon, Oxfordshire, United Kingdom

Founded Date:

2002-01-01

Contact Email:

marketing(AT)oxfordimmunotec.com

Founders:

Peter Smith

Number of Employees:

251-500

Last Funding Date:

2016-10-04

IPO Status:

Public

Industries:

© 2025 bioDAO.ai